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Abstract 
In order to delineate the specific morphological and immunophenotypic features 
of B-cell lymphoproliferative disorders associated with trisomy 12, 172 
sequential unselected cases of CD19+CD5+ B-cell disorders, primarily affecting 
the peripheral blood and bone marrow, were studied. Trisomy 12 was found in 24 
cases (13.9%), with all cases morphologically classified as either CLL-PL or CLL-
mixed by FAB criteria. Trisomy 12 was not found in any cases of typical CLL. 
Trisomy 12 cases demonstrated a significant higher expression of CD11a 
(P<0.0001) and CD20 (P<0.0006) when compared to cases with the equivalent 
morphology and immunophenotype, but without the chromosomal abnormality. 
Trisomy 12 cases also demonstrated a higher frequency of FMC7, CD38 
expression and moderate to strong surface immunoglobulin staining. However, 
no correlation was detected between the percentages of trisomy 12 cells and cells 
expressing CD11a, CD38, FMC7 or sIg mean fluorescent intensity. Cells from 
trisomy 12 positive cases were sorted according to their CD11a expression using 
fluorescent activated cell sorting. There was a significant increase in the 
percentage of trisomy 12 cells within the CD11a+ sorted fraction compared to the 
unsorted population (P<0.05), implying that trisomy 12 is associated with 
increased expression of CD11a. 
With the highly specific morphological and immunophenotypic features 
demonstrated by trisomy 12 cases in this study, it is highly likely that these 
cases constitute a specific group of B-cell lymphoproliferative disorders. 
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